Based on TARGET analysis and consistent RT-qPCR data for 45 patient samples, our results strongly suggest that the new immune-related gene signature of CD4/CD68/CSF1R has prognostic value for OSA. The gene discussed is CD68; the disease is obstructive sleep apnea syndrome.